December 05, 2018
Sponsored by
Agena Bioscience

Validating a Diagnostic Mass Spec Platform for a Molecular Pathology Service Lab

GenomeWebinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This webinar will describe how a molecular pathology laboratory selected and validated a mass spectrometry-based analysis platform for diagnostic use.

Doug Demetrick, director of the Molecular Pathology Laboratory at Calgary Laboratory Services, will share his experience implementing the Agena MassArray platform in his lab.

This presentation will focus on the Agena iPLEX HS chemistry, which enables solid tumor profiling in lung, colon, melanoma, and brain samples. Dr. Demetrick will also discuss his ongoing work to enable liquid biopsy using the Agena UltraSeek chemistry.

Sponsored by

NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.

Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.

A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.

In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.